Thiazide therapy in chronic hypoparathyroidism: effects on hypercalciuria and renal function-a systematic review and

Vivek Jha1, Mannuru Venkateswarlu2, Amal Shaharyar1

  • 1Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, Punjab, 160012, India.

Insights

Thiazide diuretics may reduce urinary calcium excretion in chronic hypoparathyroidism, but evidence is limited. Further research is needed to confirm efficacy and long-term renal safety in patients with this condition.

Area of Science:

  • Nephrology
  • Endocrinology

Background:

  • Chronic hypoparathyroidism impairs renal calcium reabsorption, leading to hypercalciuria and increased risk of kidney complications.
  • Thiazide diuretics are often used to manage hypercalciuria, but their effectiveness and safety in this context are not well-established.

Purpose of the Study:

  • To evaluate the effects of thiazide therapy on urinary calcium excretion and renal outcomes in patients with chronic hypoparathyroidism.

Main Methods:

  • A systematic literature search was conducted across major databases (PubMed/MEDLINE, Embase, Scopus, Cochrane CENTRAL).
  • Included studies were randomized and observational trials involving adults with chronic hypoparathyroidism treated with thiazides.
  • Meta-analysis was performed using a random-effects model to synthesize quantitative data.

Main Results:

  • Four studies with 64 participants were included; only two were eligible for quantitative synthesis.
  • Meta-analysis showed no significant reduction in urinary calcium excretion (SMD -0.42), with wide confidence intervals indicating substantial imprecision.
  • Qualitative data suggested a potential reduction, but pooled estimates were inconclusive due to small sample sizes, heterogeneity, and short follow-up. Renal function remained stable.

Conclusions:

  • Current evidence suggests a possible benefit of thiazides in reducing urinary calcium excretion in chronic hypoparathyroidism, but the certainty of this finding is low.
  • Inconclusive quantitative results and limited high-quality data necessitate caution.
  • Larger, prospective studies are required to definitively establish the efficacy and long-term renal safety of thiazide therapy in this patient population.
Abstract

Related Concept Videos

Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...